Coagulation and liver transplantation.
In summary, both a thorough understanding of the pathogenesis of coagulopathies and an understanding of the proper replacement and pharmacologic therapies based on TEG monitoring of coagulability are essential in the management of coagulation. As stated by Starzl, "Now cautious correction of coagulation defects is an integral part of liver transplantation, greatly diminishing the hemorrhages of nightmare proportions that were common."
Kang
Y
Y
Department of Anesthesiology, University of Pittsburgh School of Medicine, Pennsylvania 15213.
D000933:Antifibrinolytic Agents / Q000627:therapeutic use; D001777:Blood Coagulation; D016913:Blood Component Transfusion; D006487:Hemostasis; D006801:Humans; D016031:Liver Transplantation / Q000502:physiology*; D016343:Monitoring, Intraoperative
D000933:Antifibrinolytic Agents